In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
involve the managing physician
Store Vitcofol-C Injection at room temperature
HCG has one of the most extensive and diverse published research profiles of any naturally occurring hormone, with peer-reviewed literature spanning reproductive endocrinology, developmental biology, immunology, and clinical research
5-Amino-1MQ is not FDA approved as a standard treatment for anti-aging, fat loss, insulin resistance, cardiovascular disease, or general wellness